drugset / Trial / NCT06641635

Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer

NCT06641635 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The most common external beam radiotherapy fractionation scheme for cervical cancer is 45-50.4 Gy delivered in 25-28 fractions. However, prolonged treatment duration can lead to insufficient availability of medical resources. We hope to assess the safety and efficacy of moderated hypofractionated online adaptive radiotherapy in combination with brachytherapy in patients with cervical cancer in a multicenter study.

Timeline

Start
2024-11-19
Primary completion
2026-10-31
Completion
2029-10-31

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified 40 mg/m2 —

Indications